RF
IBB icon

Robbins Farley’s iShares Biotechnology ETF IBB Stock Holding History

Robbins Farley’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-71
Closed -$8.98K – 181
2025
Q2 		$8.98K Hold
71
– – ﹤0.01% 118
2025
Q1 		$9.08K Sell
71
-28,181
-100% -$3.82M ﹤0.01% 108
2024
Q4 		$3.74M Buy
28,252
+907
+3% +$128K 1.78% 30
2024
Q3 		$3.98M Buy
27,345
+116
+0.4% +$16.8K 2.01% 20
2024
Q2 		$3.74M Buy
27,229
+1,144
+4% +$153K 1.99% 19
2024
Q1 		$3.58M Buy
26,085
+988
+4% +$135K 1.88% 18
2023
Q4 		$3.41M Buy
25,097
+3,158
+14% +$385K 2.04% 18
2023
Q3 		$2.68M Buy
21,939
+2,209
+11% +$281K 1.81% 20
2023
Q2 		$2.5M Sell
19,730
-689
-3% -$89.5K 1.73% 25
2023
Q1 		$2.64M Buy
20,419
+452
+2% +$59.2K 1.76% 20
2022
Q4 		$2.62M Buy
19,967
+5,549
+38% +$717K 2.03% 22
2022
Q3 		$1.69M Buy
14,418
+6,518
+83% +$809K 1.38% 37
2022
Q2 		$929K Buy
7,900
+5,677
+255% +$674K 0.97% 35
2022
Q1 		$290K Sell
2,223
-144
-6% -$18.8K 0.22% 47
2021
Q4 		$361K Buy
2,367
+100
+4% +$15.5K 0.27% 42
2021
Q3 		$367K Buy
2,267
+65
+3% +$10.9K 0.27% 48
2021
Q2 		$360K Buy
2,202
+89
+4% +$13.7K 0.41% 31
2021
Q1 		$311K Buy
+2,113
New +$336K 0.27% 47

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Robbins Farley's IBB Position: Q3 2025 in Review

Robbins Farley sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 71 shares — an estimated $8.98K sold.

Robbins Farley first reported a position in IBB in Q1 2021 and held it in 18 quarters. The position peaked at $3.98M in Q3 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Robbins Farley reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Robbins Farley sold 71 iShares Biotechnology ETF shares in Q3 2025, an estimated $8.98K.
  • Robbins Farley first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 18 quarters.
  • Robbins Farley's iShares Biotechnology ETF position peaked at $3.98M in Q3 2024.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Robbins Farley's 13F filing for Q3 2025, filed 15 Oct 2025.